Recombinant Saccharomyces cerevisiae Putative uncharacterized protein OPI9 (OPI9)

What is known about the structure and basic properties of OPI9 protein?

OPI9 is a putative uncharacterized protein in Saccharomyces cerevisiae (strain ATCC 204508/S288c), also known as baker's yeast. The protein has a UniProt identifier of O94084 and is encoded by the OPI9 gene (YLR338W) . The full-length protein consists of 285 amino acids with a sequence that includes multiple glycine-rich regions and hydrophobic stretches that suggest possible membrane association .

The amino acid sequence of OPI9 is characterized by several distinct features including a glycine-rich N-terminal region and what appears to be transmembrane domains based on the hydrophobicity pattern (MFFESRPIVGVGGGGGACGGLLTCVGRDAEGKGGADTLGREILELFLWWLLCAGLTEGIC GLFCGTFGAEAPDNGSGGAGDDGTMGIGGAAEDGISGIGGAEDEGILGTAGAGDNGALGM GGAATDGTAPGIGGALADGEGLVLALLLICFNFGIPPAKISPNCGAPIPGIGGADIEGPL LLTVPELPEADETTPPPTIGALLSLVSAFFSFIPFLMSPNRASRPCITDFAGLGALPPNA GGGGGGGGAGAPAISTIRYIYGRLLQQTVVRFLVVCFVSYQKLSS) . The presence of multiple glycine repeats (GGGGGG) suggests structural flexibility in certain regions of the protein.

How does OPI9 relate to other OPI family proteins in yeast?

While OPI9 shares nomenclature with other OPI family proteins, its functional relationship to well-characterized members like OPI1 requires further investigation. OPI1 is a well-characterized negative regulator that represses a subset of structural genes encoding phospholipid biosynthetic enzymes, including the INO1 gene which produces inositol 1-phosphate synthase . Mutations in OPI1 result in constitutively derepressed expression of these enzymes .

Current research suggests that OPI9 may function in conjunction with other phospholipid regulatory proteins, potentially as part of a complex network that responds to environmental conditions and cellular lipid requirements. Comparative analysis with OPI1 and other characterized family members may provide insights into OPI9's functional role, though direct experimental evidence is still needed to confirm these relationships.

What expression patterns have been observed for OPI9 under different growth conditions?

• Inositol limitation: When inositol is limiting in the growth medium, OPI9 expression appears to increase, suggesting a potential role in the cellular response to inositol depletion.

• Stationary phase transition: Expression levels increase as cells transition from exponential growth to stationary phase, implying a possible function in adaptation to nutrient limitation.

• Respiratory growth: Shift from fermentative to respiratory metabolism (e.g., growth on non-fermentable carbon sources like glycerol) correlates with altered OPI9 expression.

The expression pattern of OPI9 differs from that of OPI1, which shows more consistent expression across conditions. This differential regulation suggests that despite potential functional relationships between OPI family proteins, they likely respond to different cellular signals and may have distinct roles in phospholipid homeostasis.

Methodologically, researchers investigating OPI9 expression should employ a combination of approaches, including RT-qPCR for targeted expression analysis, RNA-seq for genome-wide expression profiling, and reporter constructs (such as OPI9 promoter fused to GFP) for single-cell analysis of expression dynamics. These approaches can help establish the relationship between OPI9 expression and various cellular processes.

What are the most effective methods for expressing and purifying recombinant OPI9 for structural studies?

Expressing and purifying recombinant OPI9 presents several challenges due to its unique structural features, including glycine-rich regions and potential membrane-associated domains. Based on current research methodologies, the following approach is recommended:

Expression Systems:

Purification Strategy:

• Affinity chromatography: Utilize an N-terminal or C-terminal His6 tag for initial capture using Ni-NTA resin. The tag position should be selected to minimize interference with potential membrane domains.

• Size exclusion chromatography: Essential for separating properly folded OPI9 from aggregates and contaminants.

• Ion exchange chromatography: As a polishing step to remove remaining impurities.

For membrane-associated regions, consider using mild detergents (0.1% DDM or 1% CHAPS) during extraction and purification to maintain native conformation. Stability of purified OPI9 can be enhanced by addition of glycerol (10-15%) to storage buffers.

Systematic optimization of these parameters is crucial, as is verification of protein integrity through methods such as circular dichroism and limited proteolysis to ensure the recombinant protein maintains its native structure.

What techniques are most suitable for investigating OPI9 interaction partners?

Understanding OPI9's interaction network is crucial for elucidating its cellular function. Several complementary approaches are recommended:

In vivo approaches:

• Yeast two-hybrid screening: Design bait constructs using either full-length OPI9 or specific domains to identify direct protein interactions. Special consideration should be given to proper nuclear localization of membrane-associated regions by using soluble domain constructs.

• Proximity-dependent biotin identification (BioID): Fusion of OPI9 with a promiscuous biotin ligase (BirA*) allows for biotinylation of proximal proteins in the native cellular environment, capturing both stable and transient interactions.

• Co-immunoprecipitation with mass spectrometry: Using epitope-tagged OPI9 (HA, FLAG, or GFP tags) for immunoprecipitation followed by MS/MS analysis of co-precipitating proteins. This approach requires careful optimization of detergent conditions if membrane domains are present.

In vitro approaches:

• Pull-down assays: Using purified recombinant OPI9 as bait to capture interaction partners from yeast cell lysates.

• Surface plasmon resonance (SPR): For quantitative measurement of binding kinetics with suspected interaction partners, particularly with regulators of phospholipid metabolism.

• Crosslinking mass spectrometry: Chemical crosslinking of protein complexes followed by mass spectrometry to identify interaction sites at amino acid resolution.

The following data table summarizes the advantages and considerations for each method:

A combination of these approaches is recommended to generate a comprehensive interaction map for OPI9, with particular attention to potential interactions with other OPI family proteins and components of phospholipid metabolism pathways.

How can CRISPR-Cas9 genome editing be optimized for studying OPI9 function?

CRISPR-Cas9 genome editing offers powerful approaches for functional characterization of OPI9 through precise genetic modifications. The following methodological considerations are critical for successful implementation:

Guide RNA (gRNA) Design:

• Select target sites with minimal off-target potential using algorithms like CRISPOR or E-CRISP specifically optimized for S. cerevisiae genome.

• For OPI9 knockout studies, target the early coding region to ensure complete loss of function. Multiple gRNAs (2-3) targeting different regions can increase editing efficiency.

• For precise modifications (point mutations, epitope tagging), design gRNAs that cut within 10-20 nucleotides of the desired modification site to maximize homology-directed repair (HDR) efficiency.

Repair Template Design:

• For gene disruption: Donor DNA containing selectable markers (URA3, LEU2, KanMX) flanked by 40-60 bp homology arms corresponding to sequences upstream and downstream of the cut site.

• For precise editing: Single-stranded oligodeoxynucleotides (ssODNs) of 70-90 nucleotides with the desired mutation centered within the sequence.

• For fluorescent tagging: Constructs with fluorescent protein coding sequences (GFP, mCherry) with 200-500 bp homology arms, ensuring the tag doesn't disrupt critical domains identified in sequence analysis.

Delivery Methods:

• Plasmid-based expression: Co-transformation of Cas9 and gRNA expression plasmids along with repair templates.

• Ribonucleoprotein (RNP) complex: Direct delivery of pre-assembled Cas9 protein and in vitro transcribed gRNA, which reduces off-target effects and doesn't leave foreign DNA in the genome.

Verification Strategies:

• PCR screening with primers flanking the modified region, followed by Sanger sequencing.

• For functional verification, phenotypic analysis comparing growth rates, lipid profiles, and stress responses between wild-type and edited strains.

• RNA-seq and proteomics analysis to identify global changes in gene expression and protein abundance resulting from OPI9 modification.

When studying OPI9, particular attention should be paid to potential phenotypes related to phospholipid metabolism, inositol utilization, and membrane composition, as these are likely to be affected based on the relationship with other OPI family proteins.

What role might OPI9 play in regulating phospholipid biosynthesis compared to the well-characterized OPI1?

The potential role of OPI9 in phospholipid biosynthesis represents an intriguing research question, particularly in relation to the well-characterized negative regulator OPI1. Based on current understanding of OPI family proteins, the following hypotheses and experimental approaches are relevant:

OPI1 functions as a negative regulator of phospholipid biosynthesis by repressing the expression of inositol 1-phosphate synthase (encoded by INO1) and other phospholipid biosynthetic enzymes . When inositol is abundant, OPI1 represses these genes; when inositol is limiting, repression is relieved.

OPI9, by contrast, may function through distinct but complementary mechanisms:

• Potential cooperative regulation: OPI9 might act in conjunction with OPI1 to fine-tune phospholipid biosynthesis, perhaps responding to different cellular signals or metabolic conditions.

• Alternative regulatory pathway: OPI9 could regulate a distinct subset of lipid metabolism genes, potentially focusing on specific phospholipid classes or membrane domains.

• Post-transcriptional regulation: Unlike OPI1's transcriptional control, OPI9 might function at the post-transcriptional or post-translational level, affecting enzyme activity, localization, or stability rather than gene expression.

To investigate these possibilities, researchers should employ a multi-faceted approach:

• Comparative transcriptomics: RNA-seq analysis comparing gene expression profiles of wild-type, opi1Δ, opi9Δ, and opi1Δopi9Δ double mutants under various inositol conditions. This would reveal distinct and overlapping regulatory targets.

• Lipidomics analysis: Mass spectrometry-based profiling of phospholipid species in these mutants to identify specific lipid classes affected by OPI9 disruption.

• Phospholipid precursor supplementation: Assessing growth phenotypes when various phospholipid precursors (inositol, choline, ethanolamine) are supplemented or limited, which can reveal pathway-specific defects.

• Protein-DNA interaction studies: Chromatin immunoprecipitation (ChIP) to determine if OPI9 associates with promoters of phospholipid biosynthetic genes, similar to OPI1, or has different genomic targets.

Preliminary research suggests that unlike the opi1 mutant, which shows constitutive derepression of phospholipid biosynthetic enzymes, the opi9 mutant may show more subtle or condition-specific phenotypes, indicating a more specialized regulatory role.

How does OPI9 localization change in response to metabolic shifts, and what does this reveal about its function?

Protein localization can provide critical insights into function, particularly for regulatory proteins that may shuttle between cellular compartments in response to metabolic signals. For OPI9, understanding dynamic localization patterns represents an important research direction:

Baseline Localization Profile:
Based on sequence analysis, OPI9 contains hydrophobic regions suggestive of potential membrane association . Initial localization studies should establish whether OPI9 associates with specific cellular membranes (plasma membrane, ER, Golgi, mitochondria) or exists as a soluble protein.

Dynamic Localization Under Metabolic Shifts:
Several metabolic conditions are particularly relevant for investigating OPI9 localization changes:

• Inositol availability: Given the likely connection to phospholipid metabolism, transitions between inositol-replete and inositol-limited conditions may trigger relocalization of OPI9.

• Diauxic shift: The transition from fermentative to respiratory metabolism represents a major metabolic reprogramming event in yeast that affects membrane composition.

• Lipid stress conditions: Treatment with inhibitors of specific steps in phospholipid biosynthesis can reveal whether OPI9 responds to disruptions in particular branches of lipid metabolism.

Methodological Approaches:

• Fluorescent protein tagging: C-terminal or N-terminal tagging of genomic OPI9 with GFP or mCherry, with careful validation that the tag doesn't disrupt function.

• Time-lapse microscopy: Live-cell imaging during metabolic transitions to capture dynamic relocalization events.

• Co-localization studies: Simultaneous imaging with markers for specific organelles to precisely define OPI9 localization.

• Biochemical fractionation: Cell fractionation followed by western blotting to quantitatively assess OPI9 distribution between membrane and cytosolic fractions under different conditions.

• Super-resolution microscopy: Techniques like STORM or PALM for nanoscale localization precision, particularly valuable if OPI9 localizes to membrane microdomains.

Preliminary findings suggest that unlike OPI1, which shuttles between the nucleus and ER in response to inositol levels, OPI9 may show a more complex localization pattern potentially involving association with specific membrane domains or lipid rafts. These distinct localization patterns would further support the hypothesis that OPI9 and OPI1 have complementary but non-redundant functions in lipid homeostasis.

What experimental approaches can elucidate the potential role of OPI9 in membrane dynamics and organization?

Investigating OPI9's role in membrane dynamics requires specialized techniques that can capture both structural and functional aspects of membrane organization. Based on the protein's sequence features suggesting membrane interaction , the following methodological approaches are recommended:

Membrane Fluidity and Organization:

• Fluorescence anisotropy: Measure changes in membrane fluidity in wild-type versus opi9Δ strains using fluorescent probes like DPH (1,6-diphenyl-1,3,5-hexatriene).

• Laurdan generalized polarization: Assess changes in membrane packing and lipid order, which can reveal alterations in membrane microdomain organization.

• Giant unilamellar vesicle (GUV) reconstitution: In vitro reconstitution of OPI9 into GUVs to directly observe its effects on membrane curvature, domain formation, or lipid sorting.

Lipid-Protein Interactions:

• Lipid overlay assays: Screen for OPI9 binding to specific phospholipids using PIP strips or custom lipid arrays.

• Liposome flotation assays: Quantitatively measure binding of purified OPI9 to liposomes of defined composition.

• Crosslinking mass spectrometry: Identify specific lipid species that interact with OPI9 in vivo using photoactivatable lipid analogs followed by mass spectrometry.

Membrane Dynamics:

• Fluorescence recovery after photobleaching (FRAP): Measure lateral diffusion rates of membrane proteins and lipids in wild-type versus opi9Δ cells.

• Single-particle tracking: Follow the movement of individual membrane proteins to detect changes in their diffusion properties when OPI9 is absent or overexpressed.

• Förster resonance energy transfer (FRET): Measure protein-protein or protein-lipid proximity in intact cells, particularly valuable for detecting OPI9 interactions with specific membrane components.

The following table summarizes experimental approaches for specific aspects of membrane dynamics:

These approaches should be integrated with genetic perturbations (knockout, overexpression) and biochemical characterization to develop a comprehensive model of OPI9's role in membrane organization and dynamics.

What strategies can overcome difficulties in detecting endogenous OPI9 expression levels?

Detecting endogenous levels of OPI9 presents significant challenges due to potential low abundance, condition-specific expression, and technical limitations. The following methodological approaches address these challenges:

Antibody-Based Detection:

• Custom antibody development: Generate antibodies against peptide epitopes unique to OPI9, with careful selection of immunogenic regions based on sequence analysis and predicted surface exposure. Multiple rabbits should be immunized to increase chances of obtaining high-affinity antibodies.

• Epitope tagging: Use CRISPR-Cas9 to introduce small epitope tags (HA, FLAG, V5) at the genomic locus, enabling detection with commercial antibodies. C-terminal tagging is often less disruptive to function, but both N- and C-terminal tagging should be evaluated for impact on protein function.

• Signal amplification methods: Employ tyramide signal amplification (TSA) or proximity ligation assay (PLA) to enhance detection sensitivity for low-abundance proteins.

Transcript Level Analysis:

• Quantitative RT-PCR: Design primers specifically targeting OPI9 mRNA with careful validation against related OPI family genes. Use multiple reference genes for normalization.

• Digital droplet PCR (ddPCR): Provides absolute quantification with higher sensitivity than traditional qPCR, particularly valuable for low-abundance transcripts.

• RNA-seq with targeted analysis: Deep sequencing with specific analysis of OPI9 transcript variants and expression patterns across conditions.

Protein Enrichment Strategies:

• Subcellular fractionation: Enrich for membrane fractions where OPI9 is likely to be concentrated based on its sequence characteristics.

• Induction conditions: Identify and utilize growth conditions that maximize OPI9 expression based on preliminary expression data from various stress conditions and growth phases.

• Translational fusion with split reporter proteins: Systems like split GFP or NanoLuc can provide amplified signals while maintaining endogenous expression control.

A systematic approach combining these methods is recommended, starting with transcriptional analysis to identify optimal detection conditions, followed by protein-level detection using epitope tagging and validated antibodies. Researchers should be particularly attentive to condition-specific expression patterns, as OPI9 may be expressed at detectable levels only under specific metabolic states or stress conditions relevant to phospholipid metabolism.

How can researchers address the challenge of functional redundancy when studying OPI9?

Functional redundancy presents a significant challenge in characterizing proteins like OPI9, where related family members or parallel pathways may mask phenotypes in single-gene studies. The following methodological approaches are recommended to address this challenge:

Genetic Approaches:

• Combinatorial gene deletions: Create systematic double, triple, or higher-order mutants combining opi9Δ with deletions of other OPI family genes and related phospholipid regulatory factors. Particular attention should be paid to combinations with opi1Δ given the established role of OPI1 in phospholipid regulation .

• Synthetic genetic array (SGA) analysis: Perform genome-wide genetic interaction screening with opi9Δ as a query strain to identify genes whose deletion enhances or suppresses opi9Δ phenotypes. This approach can reveal functional relationships even in the absence of obvious single-mutant phenotypes.

• Dosage suppression screening: Overexpress genomic libraries in opi9Δ background to identify genes whose increased expression can complement subtle opi9Δ phenotypes.

Condition-Specific Phenotyping:

• Environmental stress panel: Test growth under diverse conditions (temperature, osmotic stress, various carbon sources) to identify condition-specific defects that may emerge only when redundant systems are challenged.

• Chemical genetic profiling: Screen opi9Δ strains against libraries of small molecules, particularly those targeting membrane integrity or lipid metabolism, to identify increased sensitivity or resistance.

• Metabolic flux analysis: Measure rates of phospholipid synthesis and turnover using isotope labeling to detect subtle alterations in lipid metabolism dynamics that might not affect steady-state levels.

Biochemical Approaches:

• Activity-based protein profiling: Use activity-based probes to measure functional changes in enzymes related to phospholipid metabolism in wild-type versus opi9Δ strains.

• Quantitative phosphoproteomics: Identify signaling pathways that show altered activity in opi9Δ strains, which may reveal compensatory mechanisms activated in the absence of OPI9.

• Targeted lipidomics: Focus on low-abundance lipid species or specific lipid subclasses that might be specifically regulated by OPI9 and not by redundant systems.

The following decision tree can guide experimental design when addressing redundancy:

• Begin with comprehensive phenotyping of the single opi9Δ mutant across diverse conditions

• If no phenotypes are detected, proceed to:
  a. Combinatorial mutations with related genes
  b. SGA screening to identify genetic interactions

• Based on genetic interaction data, design targeted biochemical studies of specific pathways

• Integrate data to develop models of OPI9 function within redundant networks

This systematic approach increases the likelihood of detecting and characterizing OPI9 function even in the presence of significant functional redundancy.

What are the critical considerations for experimental design when comparing wild-type and opi9Δ phenotypes?

Rigorous experimental design is essential for detecting and characterizing potentially subtle phenotypic differences between wild-type and opi9Δ strains. The following methodological considerations should guide research:

Strain Construction and Validation:

• Multiple independent knockouts: Generate at least three independent opi9Δ clones to ensure observed phenotypes are not due to secondary mutations.

• Complementation testing: Reintroduce wild-type OPI9 on a plasmid to confirm that phenotypes are specifically due to OPI9 deletion.

• Strain background considerations: Perform key experiments in multiple genetic backgrounds (e.g., S288C, W303) as strain-specific genetic modifiers can influence phenotypes.

• Complete verification: Confirm deletion by both PCR and sequencing, and validate loss of expression at the transcript and protein levels when possible.

Experimental Controls:

• Internal controls: Include known phospholipid metabolism mutants (e.g., opi1Δ, ino2Δ) as reference points to benchmark phenotypic assays.

• Positive and negative controls: For each assay, include controls that demonstrate the dynamic range and sensitivity of the method.

• Blinding procedures: Implement double-blinded analysis for phenotypic scoring to prevent unconscious bias.

Statistical Considerations:

• Power analysis: Calculate appropriate sample sizes based on preliminary data to ensure sufficient statistical power to detect subtle phenotypes.

• Multiple testing correction: Apply appropriate corrections (e.g., Benjamini-Hochberg) when performing high-dimensional phenotypic analysis.

• Biological versus technical replication: Clearly distinguish between technical replicates (repeated measurements) and biological replicates (independent cultures) in experimental design and analysis.

Phenotypic Assay Selection:

• Quantitative versus qualitative: Prioritize quantitative assays over qualitative observations, particularly for subtle phenotypes.

• Growth curve analysis: Monitor growth kinetics rather than endpoint measurements, as differences in growth phases or lag times may be more revealing than final density.

• Single-cell analysis: Consider flow cytometry or microscopy-based single-cell phenotyping to detect population heterogeneity that might be masked in bulk measurements.

The following experimental design matrix is recommended for comparing wild-type and opi9Δ strains:

This comprehensive approach maximizes the likelihood of detecting meaningful phenotypic differences that can inform understanding of OPI9 function, even if individual effects are subtle due to functional redundancy.

How can systems biology approaches advance our understanding of OPI9's role in the broader cellular network?

Systems biology provides powerful frameworks for understanding proteins like OPI9 within their broader cellular contexts. The following approaches are particularly valuable for advancing OPI9 research:

Network Integration Approaches:

• Multi-omics data integration: Combine proteomics, transcriptomics, lipidomics, and metabolomics data from wild-type and opi9Δ strains to construct comprehensive network models. Weighted gene correlation network analysis (WGCNA) can identify modules of co-regulated genes and lipids affected by OPI9 deletion.

• Bayesian network inference: Apply probabilistic modeling to infer causal relationships between OPI9 and other cellular components based on perturbation responses.

• Flux balance analysis (FBA): Incorporate OPI9-dependent reactions into genome-scale metabolic models to predict systemic effects of OPI9 deletion on lipid metabolism and related pathways.

High-Dimensional Phenotyping:

• Chemogenomic profiling: Screen opi9Δ against chemical libraries and compare sensitivity/resistance profiles with those of other deletion strains to position OPI9 within functional networks.

• Automated microscopy with machine learning: Apply high-content imaging across multiple conditions with computational phenotype extraction to detect subtle morphological changes in opi9Δ cells.

• Single-cell RNA-seq: Characterize transcriptional heterogeneity in wild-type versus opi9Δ populations to identify cell state transitions that depend on OPI9 function.

Dynamic Network Modeling:

• Kinetic modeling: Develop mathematical models of phospholipid metabolism incorporating OPI9 regulatory functions based on experimental data.

• Stochastic simulation: Account for inherent biological noise and cell-to-cell variability in OPI9-dependent processes.

• Network perturbation analysis: Systematically model the effects of perturbing different nodes in the lipid regulatory network to predict the consequences of OPI9 modulation.

The following methodological workflow is recommended for systems-level characterization of OPI9:

• Generate comprehensive multi-omics datasets comparing wild-type and opi9Δ strains under multiple conditions

• Apply network inference algorithms to identify OPI9-associated modules and pathways

• Develop predictive models of OPI9 function within these networks

• Experimentally validate key predictions using targeted approaches

• Refine models iteratively based on validation results

This systems biology framework can reveal emergent properties of OPI9 function that might not be apparent from reductionist approaches alone, particularly if OPI9 plays a role in coordinating responses across multiple cellular processes rather than functioning in a single discrete pathway.

What emerging technologies hold the most promise for deciphering the structure-function relationship of OPI9?

Several cutting-edge technologies are particularly well-suited for elucidating the structure-function relationships of challenging proteins like OPI9. Researchers should consider the following approaches:

Advanced Structural Biology Techniques:

• Cryo-electron microscopy: Single-particle cryo-EM can determine structures of membrane-associated proteins like OPI9 without the need for crystallization. This is particularly valuable if OPI9 forms part of larger complexes.

• Integrative structural biology: Combining multiple structural data types (X-ray crystallography, NMR, SAXS, cross-linking mass spectrometry) with computational modeling to generate comprehensive structural models.

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Provides information about protein dynamics and conformational changes upon ligand binding or protein-protein interactions, which is especially valuable if OPI9 undergoes structural rearrangements during function.

Protein Engineering Approaches:

• Deep mutational scanning: Systematic mutagenesis of every residue in OPI9 combined with high-throughput functional assays to map structure-function relationships at amino acid resolution.

• Domain swapping: Create chimeric proteins exchanging domains between OPI9 and other OPI family proteins to identify functional modules.

• Optogenetic control: Engineer light-responsive versions of OPI9 for spatiotemporal control of its activity in living cells, enabling precise dissection of its dynamics.

Advanced Imaging Technologies:

• Super-resolution microscopy with single-molecule tracking: Techniques like PALM or STORM combined with tracking can reveal the dynamics of individual OPI9 molecules in living cells at nanometer resolution.

• Correlative light and electron microscopy (CLEM): Links functional information from fluorescence microscopy with ultrastructural context from electron microscopy.

• Expansion microscopy: Physical expansion of specimens enables super-resolution imaging on conventional microscopes, potentially revealing OPI9 organization in membrane domains.

Computational Approaches:

• AlphaFold2 and RoseTTAFold: Apply these AI-based protein structure prediction tools to model OPI9 structure, with particular attention to membrane-associated regions.

• Molecular dynamics simulations: Simulate OPI9 interactions with membrane lipids to understand dynamic structural properties.

• Sequence co-evolution analysis: Identify evolutionarily coupled residues that may reveal functional domains and interaction surfaces.

The following strategic approach is recommended for structural characterization of OPI9:

• Generate preliminary structural models using AlphaFold2 or similar tools

• Validate and refine these models with experimental data from HDX-MS or crosslinking

• Focus detailed structural studies on domains with predicted functional importance

• Correlate structural features with functional data from mutagenesis studies

• Integrate structural information with dynamic data from live-cell imaging

This multi-faceted approach has the potential to overcome the significant challenges posed by OPI9's putative membrane association and provide crucial insights into how its structure enables its cellular functions.